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Abstract
A series of sterically shielded pyrrolidine nitroxides were synthesized and their reduction by
ascorbate (vitamin C) indicate that nitroxide 3 – a tetraethyl derivative of 3-carboxy-PROXYL – is
reduced at the slowest rate among known nitroxides, i.e., at a 60-fold slower rate than that for 3-
carboxy-PROXYL.
Nitroxide radicals have a wide range of applications in organic synthesis,1 materials
chemistry,2,3 biophysics,4 and biomedicine.5 These applications rely on the stability,
paramagnetic properties,6 and/or redox properties7 of the radicals at ambient conditions.
While fast redox reactions of nitroxide radicals are favorable for many applications, fast in
vivo reduction of paramagnetic nitroxide radicals to diamagnetic hydroxylamines by
antioxidants, such as ascorbate (vitamin C) or enzymatic systems, hinder their applications
in biomedicine.
3-Carboxy-PROXYL (1) (Figure 1) and its carboxylic acid derivatives are among the most
commonly used nitroxides in vivo because of their resistance to reduction.9 However, their
half-life is only ~2 min in the bloodstream and major organs, as determined by magnetic
resonance imaging (MRI) studies in mice.9 Therefore, their applications as paramagnetic
contrast agents in MRI or in vivo spin labels are rather limited.10
Recently, we reported the design and synthesis of an MRI contrast agent based upon
macromolecular polyradicals derived from spirocyclohexyl nitroxide 2 (Figure 1).11,12 The
agent possesses a comparatively long in vivo lifetime, high 1H water relaxivity (R1), and
provides contrast-enhanced high resolution MRI in mice for over 1 hour.11
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To further improve the development of organic based MRI contrast agents, we explore
nitroxides that are more resistant to reduction than 2. It is well-established that the slower
rate of reduction of nitroxides is associated with ring size, i.e. 5-membered (pyrrolidine) vs.
6-membered (piperidine) ring structures,9 as well as steric shielding of the nitroxide
moiety.13,14 To search for nitroxides with increased resistance to reduction, we focus on a
series of sterically shielded pyrrolidine nitroxides and their rate of reduction with ascorbate.
Typically, the rate of reduction of a nitroxide by ascorbate in vitro provides a qualitative
guideline to its expected half-life in vivo.11,14
Herein we report synthesis of sterically shielded pyrrolidine nitroxides 3 – 6 (Figure 1) and
reduction kinetics of nitroxides 1 – 6 by ascorbate.
Synthesis of nitroxide 3 is outlined in Scheme 1. Starting from 7, we followed the
desulfurization procedure using Raney Ni, which was previously reported to provide 2,2,6,6-
tetraethylpiperidine-4-one in 15% yield.15 However, we found that the major product was
alcohol 8,16 which could be obtained in about 50% yield using a larger excess of Raney Ni.
We expected that, under similar conditions for preparation of Tempone (16),17 oxidation of
8 using m-CPBA would provide 10. Instead, we obtained 9,16 which was then oxidized
further with Dess–Martin periodinane (DMP) to give ketone-nitroxide 10. By adapting the
previously reported procedure for bromination of Tempone,18 11 was obtained by
protonation of nitroxide 10, followed by bromination, and recovery of nitroxide with sodium
nitrite. Nitroxide 11 in potassium hydroxide solution at 20 °C undergoes Favorskii
rearrangement18 to give the target nitroxide 3. Treatment of 3 with N-hydroxysuccinimide
(NHS) and N,N’-dicyclohexylcarbodiimide (DCC) in THF provides spin label 3-NHS in
good yield.
The synthesis of bicyclic pyrrolidine nitroxides is based on partial Favorskii rerrangement of
12 leading to 4.19 Sodium diethyl malonate is added to a solution of a bromoketone in
anhydrous THF, and then the reaction mixture is stirred at 50 °C for 1.5 – 2.5 h, to produce
bicyclic nitroxides 4 – 6 in about 50% isolated yields as mixtures of diastereomers (Scheme
2).
Structures of nitroxides 2 and 3 are confirmed by single-crystal X-ray analysis (Figure 2).20
High purity of the bulk samples of nitroxides 3 – 6, as well as all other nitroxides used for
kinetic studies, is determined by paramagnetic 1H NMR spectra and EPR spectroscopic spin
concentrations.
EPR spectra of nitroxides 3 – 6 in chloroform show triplet patterns due to 14N hyperfine
splitting, aN ≈ 14 – 16 Gauss, and g-values of about 2.006, similar to those for 1 and 2. For
bicylic nitroxide 4, each of the triplet peaks is resolved into nonets, corresponding to
coupling of 8 protons with 1H hyperfine splitting, aH ≈ 0.5 Gauss. This EPR splitting pattern
is reproduced by DFT calculations,21 using simplified structures for cis and trans
diastereomers, in which the diethylmalonate moiety is replaced with a methyl group.
Specifically, each diastereomer has 8 protons with computed aH ≈ 0.5 Gauss, i.e., 2 protons
at the bridghead and 6 protons in the methyls that are syn to the cyclopropane moiety.22
Rates of reduction for pyrrolidine nitroxides 1 – 6 are studied under pseudo-first order
conditions using a 20-fold excess ascorbate in pH 7.4 PBS buffer. For comparison, the rates
of reduction of the gem-dimethyl, spirocyclohexyl, and gem-diethyl piperidine nitroxides 9,
10, 14 – 179,14,23 are measured under identical conditions. Second order rate constants, k,
are obtained by monitoring the decay of the low-field EPR peak height of nitroxides at 295
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K (Figure 3 and Table 1). Also, decays of EPR single integrated peak height are examined
and found to produce similar values of k for most nitroxides (Tables S5 and S6, SI).
The values of k for gem-dimethyl nitroxides 1, 14, and 16 in Table 1, which may be
compared to the corresponding k = 0.06, 5.46, 5.78 M−1s−1 at 293 K reported by Rigo,23
reflect a well-known finding that 5-membered ring nitroxides are reduced at relatively
slower rates, compared to 6-membered ring nitroxides. The gem-dimethyl bicyclic nitroxide
4 (k = 0.354 M−1s−1) is reduced at a significantly faster rate than 1 (Figure 3). The
spirocyclohexyl nitroxides 2, 5, 15, and 17 are reduced at rates that are about two times
slower than those for the corresponding gem-dimethyl nitroxides. The rates of reduction for
gem-diethyl nitroxides 3, 6, 9, and 10 are decreased by another factor of 20–70, compared to
the spirocyclohexyl nitroxides.
gem-Diethyl pyrrolidine nitroxides 3 (k ≤ 0.001 M−1s−1) and 6 (k ≈ 0.01 M−1s−1) are
reduced at significantly slower rates, compared to previously reported nitroxides, including
5-membered ring nitroxides shielded with gem-diethyl groups, such as 3,4-dimethyl-2,2,5,5-
tetraethylperhydroimidazol-1-yloxy (k = 0.02 M−1s−1).13 As illustrated in Figure 3, 0.2 mM
nitroxide 3 in the presence of a 20-fold excess of ascorbate shows no detectable decay over
3 hours. Only when much higher concentrations of 3 and ascorbate are used, the reduction
becomes detectable (Figure 4); for 1 mM 3 treated with 20 mM and 100 mM ascorbate, the
EPR signal of nitroxide 3 decreases by only 5 and 15%, respectively, after 3 hours.
The reduction profiles (Figure 4) suggest that the slow rate at the initial stage of the reaction
(k ≈ 0.001 M−1s−1, Table 1) is followed by slower decay of the EPR signal in the later stage.
This observation may be interpreted as initial slow reaction of ascorbate with nitroxide,
which produces hydroxylamine and ascorbate radical, reaching an “equlibrium” (Figure 4,
eq. 1). The equilibrium is shifted toward hydroxylamine by slow decay of ascorbate radical
via known multi-step mechanism.13,24 Addition of reduced glutathione (GSH), which is
known to scavenge ascorbate radical with k ≈ 10 M−1s−1 or dehydroascorbate
(disproportionation product of ascorbate radical),13,24,25 leads to higher conversion of
nitroxide to hydroxylamine. This effect is more pronounced at higher concentrations of
ascorbate (Figure 4). In the absence of ascorbate, GSH does not reduce stable nitroxides
(Figure S5, SI), and the initial rates of the reduction of studied nitroxides with ascorbate are
only slightly increased by addition of GSH (Table S6, SI).
The slow rate of reduction of 3 compared to that of 2 may be related to increased steric
shielding of the nitroxide moiety by gem-diethyl vs. spirocyclohexyl groups, as shown by
the space-filling plots of the X-ray structures (Figure 5).
For further insight into the structure of 5-membered ring nitroxides, geometries of 1 – 3
were optimized at the UB3LYP/6-311+G(d,p)+ZPVE level of theory;21 for 4 – 6, simplified
structures for cis and trans diastereomers, in which the diethylmalonate moiety is replaced
with a methyl group, are computed at the same level of theory. Space-filling plots for these
DFT-computed nitroxides suggest that steric shielding of the nitroxide moiety increases
from gem-dimethyl to spirocyclohexyl to gem-diethyl (Figure S6, SI). Also, steric shielding
is more effective in 1 – 3, compared to the simplified structures of 4 – 6 (Figure S7, SI).26
Thus, the experimentally observed rate constants for reduction of 1 – 6 by ascorbate may be
qualitatively correlated with steric shielding of the NO moiety in pyrrolidine nitroxides.
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Figure 1.
Pyrrolidine nitroxides.
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Figure 2.
X-ray structures for nitroxide radicals 2 (left) and 3 (right). Carbon, nitrogen, and oxygen
atoms are depicted with thermal ellipsoids set at the 50% probability level.
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Figure 3.
Reduction profiles of 0.2 mM nitroxides with 4 mM ascorbate in 25 mM PBS pH 7.4 at 295
K. (5, 6, and 17 have insufficient solubility to be included in the plot.)
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Figure 4.
Reduction profiles of 1.0 mM nitroxides in 125 mM PBS pH 7.4 at 295 K. Concentrations of
ascorbate (20 or 100 mM) and GSH (0, 5, or 25 mM) are indicated for each experiment.
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Figure 5.
Stick and space-filling plots for X-structures of 2 (left) and 3 (right). Carbon, nitrogen, and
oxygen atoms are colored in black, blue, and red, respectively.
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Scheme 1.
Synthesis of Nitroxides 3 and 3-NHS.a
a
 Isolated yields.
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Scheme 2.
Synthesis of Nitroxides 4 – 6.
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Table 1
Second order rate constants, k (M−1s−1), for initial rates of reduction of nitroxides (0.04 – 0.2 mM) with 20-
fold excess ascorbate in 25 mM PBS pH 7.4 at 295 K.a
pyrrolidine nitroxides piperidine nitroxides
k k
1 0.063 ± 0.002 14 5.6 ± 0.2
2 0.031 ± 0.003 15 2.57 ± 0.03
3 ≤0.001b 9 0.039 ± 0.003
4 0.354 ± 0.006 16 6.32 ± 0.01
5 0.170 ± 0.004 17 3.2 ± 0.2
6 0.01 10 0.044 ± 0.002
a
Mean ± two standard deviations from at least three measurements; see: Tables S5 – S6 in the SI.
b1 mM 3 with 20 or 100 mM ascorbate in 125 mM PBS.
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